Key Takeaways
- Demand snapped back after a Q3 "disaster": Q4 volumes normalized to ~17,000 tonnes as paint-industry demand revived, but full-year results were scarred by a Q3 demand collapse management called the first such disaster since 2010.
- FY24 volume growth guided at 22–25%: Management expects to cross 70,000 tonnes (up from ~57,000 in FY23), implying a sharp recovery that hinges on a normal monsoon sustaining paint demand through Diwali.
- Isostearic acid is the new growth leg: Trial runs have begun, samples are with customers in the US, Europe and Japan, and commercial shipments start in Q2 FY24; the product enters a market with only 5–6 global players and no Indian manufacturer.
- Margin recovery to 15% EBITDA is the FY24 target, but conditional: Management targets 15% plus or minus 1%, achievable only if the unprecedented vegetable-oil price volatility of the last two years does not repeat.
- What to watch next quarter: Whether isostearic acid commercial shipments begin on schedule, the volume and margin guidance management promises to provide then, and any sign that monsoon weakness threatens the Q3 paint demand assumption.
The Q3 Disaster and Q4 Recovery
- Q3 demand collapse: Management described Q3 as a "disaster" and the first such event since 2010, with a drop in demand that dragged down the full-year quantity processed and profitability.
- Q4 normalization: The January–March quarter processed ~17,000 tonnes, described as a normal volume quarter, driven by a large-scale revival in demand from the paint industry.
- Full-year scar: Even with the Q4 recovery, the annual results appear weaker because of the Q3 hole; Q2 was also acknowledged as weak.
- Customer retention held: The company did not lose any customers even through the bad Q3 results, preserving the base for the recovery.
Nahoosh Jariwala: "We saw a disaster like this for the first time."
Raw Material Volatility: The Margin Wildcard
- Unprecedented price swings: Vegetable oil prices have oscillated between Rs. 80/kg and Rs. 160/kg over the last two years, a range management says it has never seen in its 25-year history.
- Realization pass-through: Finished product prices are partly linked to vegetable oil prices, so the fall from Rs. 160 peaks to Rs. 90 dragged realization per unit down both sequentially and year-on-year.
- Y-o-Y comparison distorted: Management argued that raw material volatility makes quarter-on-quarter comparisons more meaningful than year-on-year, and that product-mix differences make quarterly realization comparisons misleading; only annual comparisons even out these effects.
- Margin conditionality: The FY24 EBITDA margin target of 15% is explicitly conditional on commodity volatility not recurring; if volatility stays absent, management says the target "won't be tough to achieve."
Nahoosh Jariwala: "This is something we have never ever seen in our 25 years' history. And this is we are seeing since last 2 years."
Isostearic Acid: The Forward-Integration Bet
- Trial runs complete, commercial shipments imminent: Trial runs have started and plant samples have been sent to companies in Japan, Europe and the USA across all three application segments (lubricants, personal care, cosmetics); response is very positive and commercial shipments begin from Q2 FY24.
- Export-led, niche market: Practically 90% of isostearic acid will be exported, targeting the US, Europe and Japan; India will be a small market. The product has only 5–6 manufacturers globally (two in Europe, two in the US, none in China) and Fairchem is the first Indian producer.
- Regulatory tailwind: Europe and the USA have new regulations requiring seafaring vessels to use biodegradable lubricants, where isostearic acid is a main ingredient; the company is consciously pivoting toward biodegradable products.
- Pricing entry strategy: Management acknowledged that entering developed markets will require pitching the product at a slight discount to competitors to gain initial interest.
- Guidance deferred: Management called it premature to provide volume, revenue or margin guidance for isostearic acid in FY24, promising to do so in the July–September quarter; all CapEx for the project is already complete.
- Competitive ambition: Management anticipates that success in isostearic acid will shift the competitive dynamic in dimer acid, asserting Chinese players "would be scared of us."
Rajen N. Jhaveri: "On the contrary, we are anticipating the other way, Mr. Khona. Chinese would be scared of us. Once we are very successful with isostearic acid, mark the words of Nahoosh bhai, Chinese would be scared of us as far as this dimer acid is concerned. But that is the future thing. Let us wait for 6 months for this."
Paint Industry: Structural Tailwind, Monsoon Risk
- Organized-sector shift: Post-GST and with new entrants like Grasim, the organized paint sector is gaining share from the unorganized sector, driving 15–20% growth for Fairchem versus 8–10% underlying market growth.
- Grasim engagement underway: Fairchem's products are under analysis at Grasim and the company is already supplying small quantities for pilot plant trials; management is confident that any large organized player entering decorative paints will have to engage with Fairchem given its linoleic acid position.
- Near-term demand visibility: Sustained sales are happening in the April–June quarter and discussions with all four big paint companies indicate no demand drop in the July–September quarter.
- Q3 demand hinges on monsoon: Management explicitly conditioned Q3 paint demand on the La Nina effect: a normal monsoon means no problems during Diwali season, but deficit rainfall would mean paint demand "might not be to the extent it should be."
Nahoosh Jariwala: "As we have linoleic acid, whatever big companies or organized companies want to come in the decorative paint segment, we will be there. They won't be able to avoid us. That's for sure."
The Abandoned Tocopherol Project and Its Afterlife
- Project history: The tocopherol upgradation project, started in 2019, was hit by COVID disruptions (lockdowns, labor migration, equipment supplier delays for ~2 years), then the Russia-Ukraine war spiking vegetable oil prices, then an incident of methanol theft by some employees that generated publicity and caused the Gujarat government to stop issuing approvals for months due to state elections.
- Conscious abandonment: By the time approvals resumed post-elections, economic considerations had turned unfavorable; the company took a conscious decision to abandon the tocopherol upgradation project.
- Asset repurposing: Most assets created for the tocopherol project can be used for a new project: upgradation of a co-product using a new raw material to produce a new prime product. 80–90% of the CapEx for this new project is already done.
- New product timeline: Commissioning is expected in Q4 FY24 (January–March quarter), with commercial quantities expected in FY25; the product will be biodegradable and, if manufactured successfully, will place Fairchem among only 5–6 players globally.
Capacity, Revenue and Market Position
- FY24 volume bridge: From ~57,000 tonnes in FY23 to 70,000+ tonnes in FY24, a rise of ~13,000 tonnes or 22–25%, based on sustaining the Q4 run-rate.
- Revenue projection: Management indicated Rs. 700 crores from 70,000 tonnes is fair, with value-added products; an earlier figure of Rs. 750 crores was also mentioned.
- Full-capacity timeline: The company expects to work at full capacity by FY25-26; historically it embarks on expansion once utilization reaches ~75%. At 1,20,000 tonnes capacity, revenue will cross Rs. 1,000 crores.
- Capacity expansion cycle: Management noted that building capacity is a minimum 3-year cycle spanning government approvals, plant design, equipment ordering, erection and commissioning.
- Dimer acid market share: Fairchem holds 65–70% of the Indian dimer acid market and is targeting further share gains.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| FY24 volume | Above 70,000 tonnes (22–25% growth from ~57,000) | FY24 full year |
| FY24 revenue | Rs. 700–750 crores | FY24 full year |
| FY24 EBITDA margin | 15% plus or minus 1%, conditional on no commodity volatility | FY24 full year |
| Isostearic acid commercial shipments | Begin shipments to US, Europe, Japan | Q2 FY24 (July–September) |
| Isostearic acid guidance | Provide volume, revenue and margin guidance | July–September quarter |
| New raw-material product commissioning | Plant commissioning | Q4 FY24 (January–March) |
| New raw-material product commercial quantities | Commercial production | FY25 |
| Q3 paint demand | Sustained demand conditional on normal monsoon and no deficit rainfall | Q3 FY24 (October–December) |
| Full capacity utilization | Work at full capacity | FY25-26 |
| Revenue at full capacity | Cross Rs. 1,000 crores | At 1,20,000 tonnes capacity |
Key Metrics
| Metric | Q4 FY23 |
|---|---|
| Operational revenue | ~Rs. 152 crores, +48% QoQ |
| EBITDA | ~Rs. 19 crores, vs Rs. 4 crores in Q3 FY23 |
| EBITDA margin | 12.64% |
| Net profit after tax | ~Rs. 12 crores, vs Rs. 60 lakhs in Q3 FY23 |
| Metric tons processed | ~17,000 tonnes |
| FY23 operational revenue | Rs. 648 crores |
| FY23 EBITDA | ~Rs. 72 crores |
| FY23 EBITDA margin | 11.17% |
| FY23 net profit after tax | ~Rs. 44 crores |
| FY23 PAT margin | 6.71% |
| FY23 metric tons processed | ~67,000 tonnes |
| FY24 projected sales | ~Rs. 750 crores |
| FY24 volume projection | above 70,000 tonnes, implying ~22% to 25% volume growth |
| Target EBITDA margin | 15% plus or minus 1% to 1.5%, on an annual basis |
| Dimer fatty acid India market share | more than 65% to 70% |
| Isostearic acid global market size | ~50,000 to 55,000 tonnes, around $400 million |
| Isostearic acid export expectation | greater than 90% |
| Capacity utilization expected to reach full | by FY25-26 |